HPSE and diabetes mellitus: Thus, along with our previously published finding that the HPSE-1 inhibitor PI-88 is effective in ameliorating diabetes in NOD mice [13], this study further supports the importance of HPSE-1 as a therapeutic target in disease conditions involving T-cell-mediated inflammatory infiltrates, such as seen in T1D.